المؤلفون: Mohammad Reza Gheini, Mohammad Ali Sahraian, Amir Reza Azimi, Naser Mmoghadasi, Mahmud Abdoli, Gelareh Rahimi, Monir Ghazaeian

المصدر: Pharmaceutical and Biomedical Research, Vol 5, Iss 4, Pp 21-26 (2019)

مصطلحات موضوعية: interferon-beta (inf-β)1b, relapsing-remitting multiple sclerosis (rrms), outcome measure, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: http://pbr.mazums.ac.ir/article-1-259-en.html; https://doaj.org/toc/2423-4494

URL الوصول: https://doaj.org/article/2963d524b7424decae3e7566d2946149